These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3554809)

  • 1. Recombinant vaccinia virus LC16m0 or LC16m8 that expresses hepatitis B surface antigen while preserving the attenuation of the parental virus strain.
    Morita M; Suzuki K; Yasuda A; Kojima A; Sugimoto M; Watanabe K; Kobayashi H; Kajima K; Hashizume S
    Vaccine; 1987 Mar; 5(1):65-70. PubMed ID: 3554809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of recombinant vaccinia virus LC16m0 or LC16m8: preserved laboratory attenuation markers and conserved expression of inserted HBsAg gene.
    Watanabe K; Morita M; Kojima A
    Vaccine; 1989 Dec; 7(6):499-502. PubMed ID: 2609725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved recombinant LC16m0 or LC16m8 vaccinia virus successfully expressing hepatitis B surface antigen.
    Watanabe K; Kobayashi H; Kajiyama K; Morita M; Yasuda A; Gotoh H; Saeki S; Sugimoto M; Saito H; Kojima A
    Vaccine; 1989 Feb; 7(1):53-9. PubMed ID: 2718607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of an attenuated vaccinia virus strain, LC16m0, and its recombinant virus vaccines.
    Sugimoto M; Yamanouchi K
    Vaccine; 1994 Jun; 12(8):675-81. PubMed ID: 8091843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen.
    Smith GL; Mackett M; Moss B
    Nature; 1983 Apr; 302(5908):490-5. PubMed ID: 6835382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Double recombinants of the vaccinia virus expressing hepatitis B virus surface antigen and herpes simplex virus thymidine kinase].
    Al'tshteĭn AD; Andzhaparidze OG; Antonova TP; Baev AA; Baĭsar D
    Dokl Akad Nauk SSSR; 1986; 289(6):1493-6. PubMed ID: 3021422
    [No Abstract]   [Full Text] [Related]  

  • 7. Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D.
    Paoletti E; Lipinskas BR; Samsonoff C; Mercer S; Panicali D
    Proc Natl Acad Sci U S A; 1984 Jan; 81(1):193-7. PubMed ID: 6320164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic properties of vaccinia virus and of the virus recombinant strains expressing heterologous genes.
    Chelyapov NV; Antonova TP; Yanova NN; Chernos VI
    Acta Virol; 1988 Sep; 32(5):409-16. PubMed ID: 2904735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene structures of low-neurovirulent vaccinia virus LC16m0, LC16m8, and their Lister original (LO) strains.
    Sugimoto M; Yasuda A; Miki K; Morita M; Suzuki K; Uchida N; Hashizume S
    Microbiol Immunol; 1985; 29(5):421-8. PubMed ID: 2993828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype.
    Buller RM; Smith GL; Cremer K; Notkins AL; Moss B
    Nature; 1985 Oct 31-Nov 6; 317(6040):813-5. PubMed ID: 4058585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A recombinant vaccinia virus expressing the middle preS2-S envelope protein of the hepatitis B virus. The induction of humoral and cellular immunity by the immunization of laboratory animals].
    Beliaev AS; Dmitriev IP; Ignat'ev GM; Mizenko GA; Putintseva NI; Sabirov AN; Samukov VV; Semënova LN; Ammosov AD; Rukavishnikov MIu
    Dokl Akad Nauk SSSR; 1990; 314(2):488-91. PubMed ID: 2265587
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope gene.
    Shida H; Hinuma Y; Hatanaka M; Morita M; Kidokoro M; Suzuki K; Maruyama T; Takahashi-Nishimaki F; Sugimoto M; Kitamura R
    J Virol; 1988 Dec; 62(12):4474-80. PubMed ID: 3184271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression.
    Flexner C; Hügin A; Moss B
    Nature; 1987 Nov 19-25; 330(6145):259-62. PubMed ID: 3118219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NYVAC: a highly attenuated strain of vaccinia virus.
    Tartaglia J; Perkus ME; Taylor J; Norton EK; Audonnet JC; Cox WI; Davis SW; van der Hoeven J; Meignier B; Riviere M
    Virology; 1992 May; 188(1):217-32. PubMed ID: 1566575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunogenicity of recombinant LC16mO vaccinia virus harboring HBsAg gene in mice.
    Watanabe K; Morita M; Sato T; Yausi K; Kojima A
    Biologicals; 1991 Apr; 19(2):77-85. PubMed ID: 1888498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the parental virus strain on the virulence and immunogenicity of recombinant vaccinia viruses expressing HBV preS2-S protein or VZV glycoprotein I.
    Kutinová L; Ludvíková V; Krystofová J; Otavová M; Simonová V; Nĕmecková S; Hainz P; Vonka V
    Vaccine; 1996 Aug; 14(11):1045-52. PubMed ID: 8879101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the virulence of wild-type thymidine kinase (tk)-deficient and tk+ phenotypes of vaccinia virus recombinants after intranasal inoculation of mice.
    Taylor G; Stott EJ; Wertz G; Ball A
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():125-30. PubMed ID: 1990060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental study of residual virulence of viral vaccine strains].
    Makhlaĭ AA; Bektimirov TA; Borisevich SV; Mikhaĭlov VV; Perekrest VV; Podkuĭko VN; Kirillov VB; Levitov AT; Ruchko VM
    Vopr Virusol; 1999; 44(2):75-8. PubMed ID: 10358902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccinia virus strain LC16m8 defective in the B5R gene keeps strong protection comparable to its parental strain Lister in immunodeficient mice.
    Yokote H; Shinmura Y; Kanehara T; Maruno S; Kuranaga M; Matsui H; Hashizume S
    Vaccine; 2015 Nov; 33(45):6112-9. PubMed ID: 26241947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of recombinant vaccinia viruses (Tian Tan strain) expressing hepatitis B virus surface antigen by using beta-galactosidase as a marker.
    Liu GQ; Cao X; Zhu JM; Ren GF; Li HM; Xie YX; Peng W
    Sci China B; 1990 Feb; 33(2):188-97. PubMed ID: 2111142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.